Lane 1: 2 μg of TGF-β 3, Human, non-reducing (NR)
Lane 2: 2 μg of TGF-β 3, Human, reducing (R)
> 95% as analyzed by SDS-PAGE

TGF-β 3, Human

Transforming growth factor beta 3(TGFB3) is a member of a TGF -β superfamily which is defined by their structural and functional similarities. TGFB3 is secreted as a complex with LAP. This latent form of TGFB3 becomes active upon cleavage by plasmin, matrix metalloproteases, thrombospondin -1, and a subset of integrins. It binds with high affinity to TGF- β RII, a type II serine/threonine kinase receptor. TGFB3 is involved in cell differentiation, embryogenesis and development. It is believed to regulate molecules involved in cellular adhesion and extracellular matrix (ECM) formation during the process of palate development. Without TGF-β3, mammals develop a deformity known as a cleft palate.

產品編號	Z03430
規格	10 μg 50 μg 1 mg 大單詢價
數量
價格	￥1560


聯系我們

產品簡介

Species

Human

Protein Construction

TGF-β3 (Ala301-Ser412)
Accession # P10600

Purity

> 95% as analyzed by SDS-PAGE

Endotoxin Level

< 1 EU/μg of protein by LAL method

Biological Activity

ED₅₀ < 0.2 ng/ml, measured in a cell proliferation assay using mouse HT-2 cells.

Expression System

Human Cells

Apparent Molecular Weight

~12.7 kDa, on SDS-PAGE under reducing conditions.

Formulation

Lyophilized from a 0.2 μm filtered solution in 4 mM HCl.

Reconstitution

It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH?O up to 100 μg/ml.

Storage & Stability

Upon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. Avoid repeated freeze-thaw cycles.

圖例

Lane 1: 2 μg of TGF-β 3, Human, non-reducing (NR)
Lane 2: 2 μg of TGF-β 3, Human, reducing (R)
> 95% as analyzed by SDS-PAGE

技術背景

Target Background

Transforming growth factor beta 3(TGFB3) is a member of a TGF -β superfamily which is defined by their structural and functional similarities. TGFB3 is secreted as a complex with LAP. This latent form of TGFB3 becomes active upon cleavage by plasmin, matrix metalloproteases, thrombospondin -1, and a subset of integrins. It binds with high affinity to TGF- β RII, a type II serine/threonine kinase receptor. TGFB3 is involved in cell differentiation, embryogenesis and development. It is believed to regulate molecules involved in cellular adhesion and extracellular matrix (ECM) formation during the process of palate development. Without TGF-β3, mammals develop a deformity known as a cleft palate.

Synonyms

Transforming growth factor beta-3; TGFB3; TGF-beta-3; Latency-associated peptide; LAP

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.

国产精品久久久久久永久牛牛,55国产福利在线视频,成人午夜精品视频在线观看

TGF-β 3, Human

資源中心

技術支持

關于我們